-
perturbation technology, AI/ML model development, or advanced molecular biology Experience in single-cell omics, spatial transcriptomics, and/or high-content imaging data analysis Demonstrated record
-
applicant will have an opportunity to work closely with a diverse scientific team that includes microbiologists, immunologists, cell biologists and bioinformaticians. Who You Are: Recent PhD in the field
-
collaborations relating to understanding disease heterogeneity through genetics, transcriptomics, imaging, and other biomarker data across human data sets. Success in these responsibilities requires a thorough
-
chemical and genetic perturbation tools coupled with high content imaging and single cell -omics to screen for regulators of disease states in complex in vitro human models Decode biological insights from
-
, spatial data, and perturbation screens with high content molecular and imaging data to understand cellular and multi cellular combinatorial programs in cells and tissues in health and disease. You will join
-
, prototype and pressure-test new ideas to reduce time between iterations Quick learner, are curious about new areas and the opportunity to build expertise, and courageously boldly and creatively take
-
cellular heterogeneity and identify genetic alterations in immune cell dysfunction. CRISPR Engineering: Develop CRISPR-engineered cell lines to model specific mutations and evaluate potential therapeutic
-
genomics datasets. Work closely with laboratory colleagues in the design of relevant experiments to develop and validate biological hypotheses. May also participate in method or technology development as a
-
the design of relevant experiments to develop and validate biological hypotheses. The applicant will also participate in method or technology development. Scientific insights resulting from this research
-
diseases. You will work in a highly collaborative group, closely interfacing with research biology and technology labs to perform cutting-edge membrane protein research while being exposed to drug discovery